CIBC World Market’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-14,187
| Closed | -$60K | – | 1221 |
|
2024
Q2 | $60K | Sell |
14,187
-625
| -4% | -$2.64K | ﹤0.01% | 1157 |
|
2024
Q1 | $75K | Sell |
14,812
-485
| -3% | -$2.46K | ﹤0.01% | 1182 |
|
2023
Q4 | $142K | Sell |
15,297
-496
| -3% | -$4.6K | ﹤0.01% | 1105 |
|
2023
Q3 | $103K | Sell |
15,793
-62
| -0.4% | -$404 | ﹤0.01% | 1098 |
|
2023
Q2 | $129K | Sell |
15,855
-183
| -1% | -$1.49K | ﹤0.01% | 1076 |
|
2023
Q1 | $137K | Sell |
16,038
-145
| -0.9% | -$1.24K | ﹤0.01% | 1104 |
|
2022
Q4 | $150K | Sell |
16,183
-136
| -0.8% | -$1.26K | ﹤0.01% | 1077 |
|
2022
Q3 | $168K | Sell |
16,319
-154
| -0.9% | -$1.59K | ﹤0.01% | 1056 |
|
2022
Q2 | $165K | Buy |
16,473
+123
| +0.8% | +$1.23K | ﹤0.01% | 1097 |
|
2022
Q1 | $201K | Buy |
16,350
+96
| +0.6% | +$1.18K | ﹤0.01% | 1165 |
|
2021
Q4 | $282K | Buy |
16,254
+517
| +3% | +$8.97K | ﹤0.01% | 1072 |
|
2021
Q3 | $282K | Buy |
+15,737
| New | +$282K | ﹤0.01% | 1088 |
|